# Cyclophosphamide

NDC: 72603-326
Generic name: Cyclophosphamide
Labeler / Manufacturer: NorthStar RxLLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS, ORAL
Marketing started: 20190510
Marketing ended: 20260531
FDA application: ANDA210046

## Active ingredients

- CYCLOPHOSPHAMIDE: 1 g/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-326"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-326
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fdaa7d15-7c06-44ab-b1d5-9d2b3e8ffd28